Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 2, 1999, Pages 165-169

  Noone, Tara C ^a   Semelka, Richard C ^a,b   Cem Balci, N ^a   Graham, Mark L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CARCINOID; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; INCIDENCE; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0032781562     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199908)10:2<165::AID-JMRI9>3.0.CO;2-Z     Document Type: Article

References (13)

1. Feigelson HS, Henderson BE, Pike MC. Re: recent trends in U.S. breast cancer incidence, survival, and mortality rate. Comment on: J Natl Cancer Inst 1996;88:1571-1579. J Natl Cancer Inst 1997;89: 1810-1812.
2. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995. Cancer 1998;82:1197-207.
3. Fumoleau P. Treatment of patients with liver metastases. Anti-Cancer Drugs 1996;7(Suppl 2):21-23.
4. Pontiggia P, Curto EC, Sabato A, Rotella GB, Alonso K. Is metastatic breast cancer, refractory to usual therapy, curable? Biomed Pharmacother 1995;49:79-82.
5. Semelka RC, Worawattanakul S, Kelekis NL, et al. Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques. J Magn Reson Imaging 1997;7:1040-1047.
6. De Lange EE, Mugler JP, Gay SB, et al. Focal liver disease: comparison of breath-hold T1-weighted MP-GRE MR imaging and contrast enhanced CT - lesion detection, localization, and characterization. Radiology 1996;200:79-84.
7. Larson RE, Semelka RC, Bagley AS, et al. Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT. Radiology 1994;192:393-399.
8. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 1992;184:687-694.
9. Stark DD, Wittenberg J, Butch RJ, Ferrucci JT Jr. Hepatic metastases: randomized, controlled comparison of detection with MR imaging and CT. Radiology 1987;165:399-406.
10. Semelka RC, Shoenut JP, Ascher SM, et al. Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging with fast-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences. J Magn Reson Imaging 1994;4:319-323.
11. Yamashita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996;200:79-84.
12. Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The frequency and significance of small hepatic lesions (< 1.5 mm) detected by CT. AJR 1992;158:535-539.
13. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999;210:71-74